mephentermine has been researched along with Ventricular Dysfunction, Left in 1 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singal, AK | 1 |
| Deepti, S | 1 |
| Sharma, G | 1 |
| Kothari, SS | 1 |
1 other study available for mephentermine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Herculean mistake: mephentermine associated cardiomyopathy.
Topics: Adult; Cardiomyopathies; Echocardiography; Embolic Stroke; Humans; Male; Mephentermine; Performance- | 2021 |